Welcome to our dedicated page for Waldencast plc SEC filings (Ticker: WALDW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Waldencast plc filings document foreign-issuer disclosures for a beauty and wellness operating company with Obagi Medical and Milk Makeup as reportable brand platforms. Form 6-K reports include financial results, business updates, product and regulatory announcements, and brand-level commentary on skin health, cosmetics, skincare and medical aesthetics.
The company’s filings also cover capital-structure and corporate matters, including credit facility refinancing, trademark asset transactions, internal control over financial reporting, restated financial results, and the concluded SEC investigation related to historical accounting practices at Obagi Cosmeceuticals.
Fitpart Fund Administration Services Ltd. reported beneficial ownership of 5,006,511 Class A ordinary shares of Waldencast plc, representing 4.4% of the class based on 112,026,440 outstanding shares plus 1,555,534 warrants deemed outstanding.
The filing states those shares are directly owned by advisory clients of Fitpart and that no single advisory client is known to beneficially own more than 5% of the Class A shares. The reporting person disclaims beneficial ownership except to the extent of any pecuniary interest, and certifies the holdings were not acquired to influence control of the issuer.
Waldencast plc submitted a Form 6-K to share that it issued a press release on August 18, 2025 providing business and financial updates for the first half of 2025. The release highlights strong progress on key business priorities and outlines initiatives designed to drive the company’s broader transformation.